Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy
Ting Tangab,
Xiao Sun*c,
Xuedong Xud,
Yifeng Biana,
Xiaojie Maa and
Ning Chen*a
aJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, 210029, China. E-mail: dentistchenning@126.com
bDepartment of Dental Implantology, Hefei Stomatology Hospital, Clinical School of Anhui Medical University, Hefei, 230001, China
cDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore. E-mail: xiaosun8000@163.com
dChina Shijiazhuang Pharmaceutical Group Co., Ltd., Shijiazhuang, 050038, China
First published on 5th March 2019
Abstract
Correction for ‘Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy’ by Ting Tang et al., RSC Adv., 2019, 9, 2559–2566.
The authors regret that Scheme 1 in the original article included some incorrect data under the cancer chemotherapy part of the scheme. The correct version of Scheme 1 is presented below.
 | ||
| Scheme 1 | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2019 |